Want to see QTEX full AI Analyst Report?
QTEX Stock Chart & Stats
$0.96
-$0.05(-4.95%)
At close: 4:00 PM EST
$0.96
-$0.05(-4.95%)
Day’s Range― - ―
52-Week Range$0.28 - $3.85
Previous CloseN/A
VolumeN/A
Average Volume (3M)330.47K
Market Cap
$39.90M
Enterprise Value$27.91
Total Cash (Recent Filing)$2.13M
Total Debt (Recent Filing)$640.00K
Price to Earnings (P/E)―
Beta3.55
Next Earnings
Apr 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding43,579,260
10 Day Avg. Volume227,613
30 Day Avg. Volume330,466
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)11.48
Price to Sales (P/S)92.25
P/FCF Ratio-2.68
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.1
Revenue Forecast (FY)$48.00M
Bulls Say, Bears Say
Bulls Say
Technical Validation Of InterconnectsIndependent RF qualification demonstrating broadband transmission, industry-leading isolation and picosecond timing is a durable technical milestone. It removes a key scaling barrier for dense quantum hardware, strengthens product defensibility, and materially improves the firm's ability to convert engineering IP into customer engagements over months to years.
Manufacturing & IP Acquisition (AME)Acquiring AME product lines, equipment and IP materially broadens vertical control from materials to finished components. This durable manufacturing and IP base accelerates commercialization, shortens time-to-customer, and supports higher-margin, differentiated hardware offerings across quantum and harsh-environment markets.
Enterprise Customer TractionA Fortune 500 purchase order signals enterprise-level validation and a path to recurring, higher-value sales. Durable commercial wins like this de-risk go-to-market execution, support scale-up of production processes, and create referenceability that helps win additional tier‑1 customers over subsequent quarters.
Bears Say
Persistent Cash BurnSustained negative operating and free cash flow implies ongoing reliance on external financing to fund operations and R&D. Over a multi‑month horizon this limits strategic flexibility, increases dilution or covenant risk with new financings, and can constrain the firm’s ability to scale manufacturing or support longer product qualification cycles.
Minimal, Inconsistent Revenue And Negative Gross ProfitVery low and volatile revenues with negative gross margin indicate the business has not yet achieved scalable commercial economics. This undermines the durability of any revenue claims, delays pathway to sustainable margins, and raises risk that technical wins will not translate into consistent, profitable sales within the next several quarters.
Eroding Equity & Balance-sheet PressureAlthough headline leverage is moderate, materially declining equity and negative returns reflect erosion from losses. This persistent capital depletion raises solvency and refinancing risk over time, narrows financing options, and increases the likelihood of future dilution or restrictive financing terms as the company scales.
QTREX Quantum Ltd News
QTEX FAQ
What was QTREX Quantum Ltd’s price range in the past 12 months?
QTREX Quantum Ltd lowest stock price was $0.28 and its highest was $3.85 in the past 12 months.
What is QTREX Quantum Ltd’s market cap?
QTREX Quantum Ltd’s market cap is $39.90M.
When is QTREX Quantum Ltd’s upcoming earnings report date?
QTREX Quantum Ltd’s upcoming earnings report date is Apr 01, 2027 which is in 221 days.
How were QTREX Quantum Ltd’s earnings last quarter?
Currently, no data Available
Is QTREX Quantum Ltd overvalued?
According to Wall Street analysts QTREX Quantum Ltd’s price is currently Overvalued.
Does QTREX Quantum Ltd pay dividends?
QTREX Quantum Ltd does not currently pay dividends.
What is QTREX Quantum Ltd’s EPS estimate?
QTREX Quantum Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does QTREX Quantum Ltd have?
QTREX Quantum Ltd has 43,579,260 shares outstanding.
What happened to QTREX Quantum Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of QTREX Quantum Ltd?
Currently, no hedge funds are holding shares in QTEX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
QTREX Quantum Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Positive
Last 7 Days ▲ 14.6%
Last 30 Days ▲ 11.0%
Last 30 Days ▲ 11.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-20.28%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-33.82%
Trailing 12-Months
Company Description
QTREX Quantum Ltd
QTREX Quantum Ltd. is an Israel-based specialized medical device firm. Its core activities encompass the research, development, manufacturing, and commercialization of unique life support technologies aimed at treating acute respiratory failure. The company provides the INSPIRA ART100, a vital life support system designed for cardiopulmonary bypass procedures lasting up to six hours. Additionally, it offers the HYLA blood sensor, engineered to deliver real-time sampling and analysis of critical blood parameter measurements. Founded in 2018, the company previously operated as Inspira Technologies Oxy B.H.N. Ltd. before rebranding to QTREX Quantum Ltd. in May 2026. Its primary operations are headquartered in Ra'anana, Israel.
Technical Analysis
Ownership Overview
6.84% Insiders
<0.01% Mutual Funds
0.47% Other Institutional Investors
92.59% Public Companies and
Individual Investors